Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Infection
Published in: Infection 5/2014

01-10-2014 | Erratum

Erratum to: Oxacillin-susceptible methicillin-resistant Staphylococcus aureus (OS-MRSA), a hidden resistant mechanism among clinically significant isolates in the Wessex region/UK

Authors: K. Saeed, N. Ahmad, M. Dryden, N. Cortes, P. Marsh, A. Sitjar, S. Wyllie, S. Bourne, J. Hemming, C. Jeppesen, S. Green

Published in: Infection | Issue 5/2014

Login to get access

Excerpt

During the editing of Fig. 1 the last bar labelled “6” does not have the clue below and it should be …
Metadata
Title
Erratum to: Oxacillin-susceptible methicillin-resistant Staphylococcus aureus (OS-MRSA), a hidden resistant mechanism among clinically significant isolates in the Wessex region/UK
Authors
K. Saeed
N. Ahmad
M. Dryden
N. Cortes
P. Marsh
A. Sitjar
S. Wyllie
S. Bourne
J. Hemming
C. Jeppesen
S. Green
Publication date
01-10-2014
Publisher
Springer Berlin Heidelberg
Published in
Infection / Issue 5/2014
Print ISSN: 0300-8126
Electronic ISSN: 1439-0973
DOI
https://doi.org/10.1007/s15010-014-0663-8

Other articles of this Issue 5/2014

Infection 5/2014 Go to the issue

Clinical and Epidemiological Study

Infective endocarditis in Rio de Janeiro, Brazil: a 5-year experience at two teaching hospitals

Case Report

An imported case of acute pulmonary coccidioidomycosis in an Italian traveller

Clinical and Epidemiological Study

Antibiotic de-escalation in bacteremic urinary tract infections: potential opportunities and effect on outcome

Clinical and Epidemiological Study

Clinical course and quality of care in ART-naïve patients newly presenting in a HIV outpatient clinic

Case Report

A case of acute myocarditis associated with Chlamydia trachomatis infection: role of cardiac MRI in the clinical management

Case Report

Disseminated Nocardia paucivorans infection in an immunocompetent host
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Pediatric Cardiology Video

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

Cardiopulmonary Comorbidity Video

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Valvular Heart Disease Video

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

Watch now

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits